Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from the ocean study

Bone ◽  
2011 ◽  
Vol 48 ◽  
pp. S92-S93
Author(s):  
R. Eastell ◽  
S. Nagase ◽  
S. Boonen ◽  
T. Spector ◽  
M. Small ◽  
...  
Keyword(s):  
Cathepsin K ◽  
Efficacy And Safety ◽  
Cathepsin K Inhibitor ◽  
Ocean Study ◽  
Post Menopausal

scholarly journals The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study

2014 ◽  
Vol 29 (3) ◽  
pp. 629-638 ◽  
Author(s):  
Klaus Engelke ◽  
Shinichi Nagase ◽  
Thomas Fuerst ◽  
Maria Small ◽  
Tomohiro Kuwayama ◽  
...  
Keyword(s):  
Cortical Bone ◽  
Postmenopausal Osteoporosis ◽  
Cathepsin K ◽  
Cathepsin K Inhibitor ◽  
Ocean Study

scholarly journals Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: The OCEAN study

2011 ◽  
Vol 26 (6) ◽  
pp. 1303-1312 ◽  
Author(s):  
Richard Eastell ◽  
Shinichi Nagase ◽  
Michiyo Ohyama ◽  
Maria Small ◽  
James Sawyer ◽  
...  
Keyword(s):  
Postmenopausal Osteoporosis ◽  
Cathepsin K ◽  
Safety And Efficacy ◽  
Cathepsin K Inhibitor ◽  
Ocean Study

Efficacy and safety of the cathepsin K inhibitor, ONO-5334, in the treatment of postmenopausal osteopenia or osteoporosis

Bone ◽  
2010 ◽  
Vol 47 ◽  
pp. S50
Author(s):  
R. Eastell⁎ ◽  
S. Nagase ◽  
S. Boonen ◽  
T. Spector ◽  
M. Small ◽  
...  
Keyword(s):  
Cathepsin K ◽  
Efficacy And Safety ◽  
Cathepsin K Inhibitor ◽  
Postmenopausal Osteopenia
Sign in / Sign up

Export Citation Format

Share Document